Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719679 · ClinicalTrials.gov registry record · NA
School Located Adolescent Vaccination Study
A NA study of School Located Vaccine Program, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 2
- Study locations
NCT01719679: Completed NA study of School Located Vaccine Program, sponsored by University of Colorado, Denver.
NCT01719679 is a NA study of School Located Vaccine Program that has completed, run by University of Colorado, Denver. The registered enrollment target is 2,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01719679, a NA study of School Located Vaccine Program, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertussis (Tdap), human papillomavirus (HPV), and meningococcal conjugate vaccine (MCV4) and all three combined) among eligible students enrolled in schools with a comprehensive school-based immunization program will be significantly higher than that of students enrolled in schools without a school-based immunization program.
Primary Outcome
The vaccination status of eligible students enrolled at participating schools will be assessed at the beginning of the school year and at the end of the school year using immunization data from the school, the state registry, community vaccinator registry, and parent records. The assessment will occur in both intervention and control settings.
Conditions Studied
Interventions
- BEHAVIORAL School Located Vaccine (SLV) Program
Study Locations (2)
Colorado
- University of Colorado Denver - Aurora
- Kaiser Permanente Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01719679 record still lists
NCT01719679 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).
The record links to 1 condition, with School Located Vaccine Program appearing as the primary indexed condition, and to 1 intervention - of which School Located Vaccine (SLV) Program is the first listed.
NCT01719679 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01719679 about?
NCT01719679 is a clinical study titled "School Located Adolescent Vaccination Study". The provision of adolescent vaccination in a school setting will be feasible and acceptable to parents as evidenced by the number and percentage of students immunized within each school compared to those in schools without a program. The likelihood of vaccination for diphtheria, tetanus, and pertuss...
What is the current status of trial NCT01719679?
This trial is currently completed. It is a NA study. The enrollment target is 2,000 participants. The study started on 2010-08. Estimated completion is 2011-10.
What conditions does trial NCT01719679 study?
This clinical trial studies the following conditions: School Located Vaccine Program.
What interventions are being tested in trial NCT01719679?
The interventions under investigation include: School Located Vaccine (SLV) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01719679?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01719679 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01719679's enrollment target sits among peer trials
2,000 52nd of 2000 higher than 1,947 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia